Scientific Committee

Terms of reference

The Scientific Committee assists the Board review the quality of UCB R&D science and its competitive standing. It assesses the strategy proposed by UCB management in R&D matters and communicates its recommendations to the Board.

The members of the Scientific Committee are also closely involved in the activities of the UCB Scientific Advisory Board (SAB) composed of external leading scientific medical experts. SAB was created in September 2005 by the Executive Committee to critically review the R&D activities of UCB, to provide scientific appraisal and strategic input as to the best way for UCB to become a robust and thriving biopharmaceutical leader and to advise the Executive Committee on the strategic choices related to early stage R&D. The Scientific Committee’s main task is to report to the Board of Directors on the SAB’s appraisal of UCB's research activities and strategic orientations.

Composition

The Committee is composed of two members who have outstanding scientific medical expertise

Functioning

The members of the Scientific Committee attend the meetings of the SAB and meet regularly with the Executive Vice President & President UCB NewMedicines. The Scientific Committee reports to the Board after each SAB meeting.